Klinrisk

Predicting Risk to Prevent Chronic Disease Progression

Business Model
B2B
Last Round
GrantJan 2023
Rounds
1

About

Klinrisk is an AI-enabled clinical diagnostics company that develops lab-based risk prediction tools for chronic disease, with its flagship product identifying progressive kidney disease before kidney function is lost. Its machine learning algorithm analyzes routinely collected blood and urine lab data to generate a Klinrisk Score, enabling clinicians to detect CKD progression earlier than standard measures and guide treatment decisions proactively. The company partners with major healthcare and pharmaceutical organizations including LifeLabs, Eli Lilly, and Bayer, and its Klinrisk Score has been recognized in the KDIGO 2024 CKD Clinical Practice Guideline.

Summary

Klinrisk is a Healthcare company based in Canada. Its most recent funding was a Grant round in Jan 2023. Investors include National Kidney Foundation.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantJan 2023

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Klinrisk on Indexed.vc
<a href="https://indexed.vc/companies/klinrisk"><img src="https://indexed.vc/api/badge/company/klinrisk" alt="Klinrisk on Indexed.vc" width="260" height="76" /></a>